scholarly article | Q13442814 |
meta-analysis | Q815382 |
P356 | DOI | 10.1016/S2214-109X(17)30340-6 |
P698 | PubMed publication ID | 28967610 |
P50 | author | Rose McGready | Q37609428 |
Freya Fowkes | Q42800053 | ||
P2093 | author name string | Julie A Simpson | |
Kerryn A Moore | |||
Michelle J L Scoullar | |||
P2860 | cites work | Bias in meta-analysis detected by a simple, graphical test | Q24685585 |
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration | Q27860581 | ||
Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting | Q27861077 | ||
The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015 | Q28267425 | ||
Timing of malaria infection during pregnancy has characteristic maternal, infant and placental outcomes | Q28533567 | ||
Intermittent preventive therapy with sulfadoxine-pyrimethamine for malaria in pregnancy: a cross-sectional study from Tororo, Uganda | Q28536733 | ||
National, regional, and worldwide estimates of stillbirth rates in 2015, with trends from 2000: a systematic analysis | Q30062081 | ||
Burden of Malaria during Pregnancy in Areas of Stable and Unstable Transmission in Ethiopia during a Nonepidemic Year | Q30233408 | ||
Making stillbirths count, making numbers talk - issues in data collection for stillbirths | Q33519170 | ||
Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study | Q33528929 | ||
Mediation of the effect of malaria in pregnancy on stillbirth and neonatal death in an area of low transmission: observational data analysis | Q33654931 | ||
Placental infections with histologically confirmed Plasmodium falciparum are associated with adverse birth outcomes in India: a cross-sectional study | Q33786153 | ||
Effect of repeated treatment of pregnant women with sulfadoxine-pyrimethamine and azithromycin on preterm delivery in Malawi: a randomized controlled trial | Q34341776 | ||
Intermittent preventive treatment of malaria with sulphadoxine-pyrimethamine during pregnancy in Burkina Faso: effect of adding a third dose to the standard two-dose regimen on low birth weight, anaemia and pregnancy outcomes | Q34372476 | ||
Stillbirths: economic and psychosocial consequences | Q34510229 | ||
Stillbirths: rates, risk factors, and acceleration towards 2030. | Q34510234 | ||
Effect of Malaria and Geohelminth Infection on Birth Outcomes in Kumasi, Ghana | Q34533872 | ||
Malaria associated symptoms in pregnant women followed-up in Benin | Q34790559 | ||
Lopinavir/ritonavir-based antiretroviral treatment (ART) versus efavirenz-based ART for the prevention of malaria among HIV-infected pregnant women | Q34974794 | ||
Malaria in pregnancy: the difficulties in measuring birthweight | Q35054459 | ||
Evaluation of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy: a retrospective birth outcomes study in Mansa, Zambia | Q35082469 | ||
What is the burden of submicroscopic malaria in pregnancy in central India? | Q35652140 | ||
Treatment policy change to dihydroartemisinin-piperaquine contributes to the reduction of adverse maternal and pregnancy outcomes | Q35690046 | ||
A Non-Inferiority, Individually Randomized Trial of Intermittent Screening and Treatment versus Intermittent Preventive Treatment in the Control of Malaria in Pregnancy | Q35741292 | ||
Associations of body mass index and gestational weight gain with term pregnancy outcomes in urban Cameroon: a retrospective cohort study in a tertiary hospital | Q35873664 | ||
Prevalence of Plasmodium falciparum resistance markers to sulfadoxine-pyrimethamine among pregnant women receiving intermittent preventive treatment for malaria in Uganda | Q35960861 | ||
The A581G Mutation in the Gene Encoding Plasmodium falciparum Dihydropteroate Synthetase Reduces the Effectiveness of Sulfadoxine-Pyrimethamine Preventive Therapy in Malawian Pregnant Women | Q35965229 | ||
Lack of effect of intermittent preventive treatment for malaria in pregnancy and intense drug resistance in western Uganda | Q36094714 | ||
Effectiveness of Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine During Pregnancy on Maternal and Birth Outcomes in Machinga District, Malawi | Q36466975 | ||
Intermittent screening and treatment or intermittent preventive treatment with dihydroartemisinin-piperaquine versus intermittent preventive treatment with sulfadoxine-pyrimethamine for the control of malaria during pregnancy in western Kenya: an op | Q36478633 | ||
Epidemiology and burden of malaria in pregnancy | Q36717617 | ||
Impact of malaria during pregnancy on pregnancy outcomes in a Ugandan prospective cohort with intensive malaria screening and prompt treatment | Q36811690 | ||
Dihydroartemisinin-Piperaquine for the Prevention of Malaria in Pregnancy | Q36843561 | ||
Implementation of intermittent preventive treatment in pregnancy with sulphadoxine/pyrimethamine (IPTp-SP) at a district health centre in rural Senegal | Q36987050 | ||
Adverse birth outcomes in United Republic of Tanzania--impact and prevention of maternal risk factors | Q37084492 | ||
Intermittent preventive treatment of malaria in pregnancy: a new delivery system and its effect on maternal health and pregnancy outcomes in Uganda. | Q37108637 | ||
Interpretation of tests of heterogeneity and bias in meta-analysis | Q37329334 | ||
Burden of malaria in pregnancy in Jharkhand State, India | Q37348544 | ||
Prevalence of malaria and sexually transmitted and reproductive tract infections in pregnancy in sub-Saharan Africa: a systematic review | Q37848714 | ||
Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women | Q38393759 | ||
Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine | Q38920997 | ||
Adverse birth outcomes in a malarious area | Q39116049 | ||
Malaria infection of the placenta in The Gambia, West Africa; its incidence and relationship to stillbirth, birthweight and placental weight | Q39342937 | ||
Prevalence and risk factors of Plasmodium falciparum infections in pregnant women of Luanda, Angola | Q39546031 | ||
Increased postpartum blood loss in pregnancies associated with placental malaria | Q39785170 | ||
Assessing malaria burden during pregnancy in Mali. | Q40448387 | ||
Changing Trends in P. falciparum Burden, Immunity, and Disease in Pregnancy | Q40942459 | ||
Comparison of intermittent preventive treatment with chemoprophylaxis for the prevention of malaria during pregnancy in Mali | Q41913039 | ||
Malaria during pregnancy: neonatal morbidity and mortality and the efficacy of chloroquine chemoprophylaxis | Q41938634 | ||
Placental and neonatal outcome in maternal malaria | Q42215406 | ||
Effectiveness of co-trimoxazole to prevent Plasmodium falciparum malaria in HIV-positive pregnant women in sub-Saharan Africa: an open-label, randomized controlled trial | Q42249162 | ||
Effects of placental malaria on mothers and neonates from Zaire | Q43443708 | ||
Birth outcomes in adolescent pregnancy in an area with intense malaria transmission in Tanzania | Q43946720 | ||
The impact of a national impregnated bed net programme on the outcome of pregnancy in primigravidae in The Gambia | Q44174341 | ||
Placental malaria and the relationship to pregnancy outcome at Gushegu District Hospital, Northern Ghana | Q44424266 | ||
Aetiology of late fetal death in Maputo | Q45013898 | ||
Low body mass index, anaemia and poor perinatal outcome in a rural hospital in eastern Sudan | Q46337610 | ||
Effect of maternal HIV and malaria infection on pregnancy and perinatal outcome in Zimbabwe | Q46348110 | ||
Perinatal outcome in an obstetric cohort of Mozambican women | Q46353623 | ||
The effect of placental malaria infection on perinatal mortality in rural Malawi. | Q46361633 | ||
Impact of asymptomatic maternal malaria parasitaemia at parturition on perinatal outcome | Q46744768 | ||
Fetal and maternal hemodynamics in acute malaria during pregnancy | Q46975438 | ||
Pregnancy outcome among grand multiparous women at the University of Maiduguri Teaching Hospital: A case control study | Q47837945 | ||
The effect of dual infection with HIV and malaria on pregnancy outcome in western Kenya | Q47923816 | ||
Declining Malaria Transmission and Pregnancy Outcomes in Southern Mozambique | Q47933012 | ||
Superiority of 3 over 2 doses of intermittent preventive treatment with sulfadoxine-pyrimethamine for the prevention of malaria during pregnancy in mali: a randomized controlled trial | Q47985735 | ||
Malaria and Perinatal Mortality in Central Sudan | Q57207614 | ||
P433 | issue | 11 | |
P921 | main subject | malaria | Q12156 |
stillbirth | Q745832 | ||
pregnancy-associated malaria | Q7239883 | ||
P304 | page(s) | e1101-e1112 | |
P577 | publication date | 2017-09-26 | |
P1433 | published in | The Lancet Global Health | Q27667673 |
P1476 | title | Quantification of the association between malaria in pregnancy and stillbirth: a systematic review and meta-analysis | |
P478 | volume | 5 |
Q99569236 | Deleterious effects of malaria in pregnancy on the developing fetus: a review on prevention and treatment with antimalarial drugs |
Q56363419 | Diagnostic accuracy of loop-mediated isothermal amplification (LAMP) for screening malaria in peripheral and placental blood samples from pregnant women in Colombia |
Q96430687 | Evidence for treating malaria with artemisinin-based combination therapy in the first trimester of pregnancy |
Q99629499 | Healthcare at the Beginning of Life and Child Survival: Evidence from a Cash Transfer Experiment in Nigeria |
Q93083170 | Impact of Plasmodium falciparum malaria and intermittent preventive treatment of malaria in pregnancy on the risk of malaria in infants: a systematic review |
Q98161912 | Innate immune responses to malaria-infected erythrocytes in pregnant women: Effects of gravidity, malaria infection, and geographic location |
Q94602401 | Malaria vaccines: facing unknowns |
Q98176809 | Modelling the incremental benefit of introducing malaria screening strategies to antenatal care in Africa |
Q89595553 | PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study |
Q99582268 | Placental Malaria |
Q96121253 | Pregnancy outcomes and risk of placental malaria after artemisinin-based and quinine-based treatment for uncomplicated falciparum malaria in pregnancy: a WorldWide Antimalarial Resistance Network systematic review and individual patient data meta-an |
Q92666131 | Pregnancy-specific malarial immunity and risk of malaria in pregnancy and adverse birth outcomes: a systematic review |
Q41992380 | Stillbirths: the hidden burden of malaria in pregnancy |
Q98292662 | Systematic review of microeconomic analysis of pregnancy-associated malaria |
Q54217436 | The Hidden Burden of Plasmodium vivax Malaria in Pregnancy in the Amazon: An Observational Study in northwestern Brazil |
Q92940778 | The invisible burden of malaria-attributable stillbirths |
Q62486720 | Trends in comparative efficacy and safety of malaria control interventions for maternal and child health outcomes in Africa: a study protocol for a Bayesian network meta-regression exploring the effect of HIV and malaria endemicity spectrum |
Search more.